Recall on Zantac: what patients and providers need to know
drugs-and-therapeutics
In 2020, recalls on Zantac (ranitidine) were issued worldwide after regulators found NDMA, a probable human carcinogen, in some batches and at higher levels when the drug was st...
Open article